Hennion & Walsh Asset Management, Inc. Pliant Therapeutics, Inc. Put Options Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
175Shares Held
65.8MCall Options Held
230KPut Options Held
746K-
Deep Track Capital, LP Greenwich, CT5.97MShares$18.2 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$15.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$14.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$9.82 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$9.72 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $148M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...